Correlation Between Apellis Pharmaceuticals and Hemagen Diagnostics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Hemagen Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Hemagen Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Hemagen Diagnostics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Hemagen Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Hemagen Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Hemagen Diagnostics.
Diversification Opportunities for Apellis Pharmaceuticals and Hemagen Diagnostics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apellis and Hemagen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Hemagen Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemagen Diagnostics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Hemagen Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemagen Diagnostics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Hemagen Diagnostics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Hemagen Diagnostics
If you would invest 0.01 in Hemagen Diagnostics on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Hemagen Diagnostics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 6.43% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Hemagen Diagnostics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Hemagen Diagnostics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apellis Pharmaceuticals and Hemagen Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Hemagen Diagnostics
The main advantage of trading using opposite Apellis Pharmaceuticals and Hemagen Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Hemagen Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemagen Diagnostics will offset losses from the drop in Hemagen Diagnostics' long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Hemagen Diagnostics vs. Prothena plc | Hemagen Diagnostics vs. Akero Therapeutics | Hemagen Diagnostics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |